MYD88 Mutation Analysis
MYD88 Gene Mutation, lymphoplasmacytic lymphoma, Waldenstrom macroglobulinemia, IgM, monoclonal gammopathy of undetermined significance, MYD, L265P, Waldenstrom, GMYDG
Test Codes
EPIC: LAB3643, Beaker: GMYDG
Department
Molecular Pathology
Specimen Collection Criteria
Collect: Blood OR Bone Marrow.
- Blood: 10.0 mL in Lavender-top EDTA tubes or Yellow-top ACD tubes. (Minimum: 5.0 mL)
- Bone Marrow: 1.0 mL in a Lavender-top EDTA tube. (Minimum: 0.5 mL)
Physician Office/Draw Specimen Preparation
Do not freeze specimens. Maintain specimen refrigerated (preferred) (2-8°C or 36-46°F) or at room temperature (20-26°C or 68-78.8°F) prior to transport.
Preparation for Courier Transport
Transport: Whole blood or bone marrow refrigerated (preferred) (2-8°C or 36-46°F) or at room temperature (20-26°C or 68-78.8°F).
Rejection Criteria
- Frozen specimens.
- Centrifuged specimens.
- Mislabeled or Unlabeled tubes.
- Specimens collected in heparin tubes (Green-top), clot tubes (Red-top), or SST (Gold-top) tubes.
- Specimens not collected and processed as indicated.
Clients will be notified of any cancellations of testing.
In-Lab Processing
Do not freeze specimens. Maintain specimen refrigerated (2-8°C or 36-46°F) prior to testing.
Storage
Specimen Stability for Testing:
Room Temperature (20-26°C or 68-78.8°F): 72 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Unacceptable
Specimen Storage in Department Prior to Disposal:
Refrigerated (2-8°C or 36-46°F): 7 days
Extracted DNA may be available for additional testing if clinically indicated. Contact the Molecular Pathology Laboratory for verification.
Laboratory
Royal Oak Molecular Pathology Laboratory
Performed
Once per week.
Results available in 7-10 days.
Test Methodology
Genomic DNA is isolated from peripheral blood or bone marrow aspirate. Allele-specific qualitative real-time PCR is used to detect the MYD88 L265P point mutation.
Interpretation
The test detects a point mutation in the MYD88 gene (MYD88 p.L265P). Results are reported as positive or negative.
Clinical Utility
The MYD88 L265P point mutation is detected in most patients with Waldenstrom macroglobulinemia / lymphoplasmacytic lymphoma and a significant proportion of patients with IgM monoclonal gammopathy of undetermined significance. It is infrequently detected in patients with chronic lymphocytic leukemia, gastric-associated lymphoid tissue lymphoma, marginal zone lymphoma and diffuse large B-cell lymphoma (activated B-cell type). It is not detected in patients with plasma cell myeloma, including IgM myeloma.
Reference
Negative (no mutation).
CPT Codes
81305
Contacts
Molecular Pathology Lab – RO
248-551-0073
Name: Molecular Pathology Lab – RO
Location:
Phone: 248-551-0073
Last Updated
11/6/2024
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.